Cargando…
A nanoparticle vaccine displaying the ookinete PSOP25 antigen elicits transmission-blocking antibody response against Plasmodium berghei
BACKGROUND: Safe and effective vaccines are crucial for the control and eventual elimination of malaria. Novel approaches to optimize and improve vaccine efficacy are urgently required. Nanoparticle-based delivery platforms are considered potent and powerful tools for vaccine development. METHODS: I...
Autores principales: | Yao, Guixiang, Min, Hui, Yu, Xinxin, Liu, Fei, Cui, Liwang, Cao, Yaming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626823/ https://www.ncbi.nlm.nih.gov/pubmed/37932796 http://dx.doi.org/10.1186/s13071-023-06020-8 |
Ejemplares similares
-
Characterization of PSOP26 as an ookinete surface antigen with improved transmission-blocking activity when fused with PSOP25
por: Wang, Peng-peng, et al.
Publicado: (2022) -
Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate
por: Zheng, Wenqi, et al.
Publicado: (2017) -
Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine
por: Kou, Xu, et al.
Publicado: (2016) -
Erratum to: Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine
por: Kou, Xu, et al.
Publicado: (2017) -
Role of Plasmodium berghei ookinete surface and oocyst capsule protein, a novel oocyst capsule-associated protein, in ookinete motility
por: Nakayama, Kazuhiko, et al.
Publicado: (2021)